Cancer cells exploit genomic instability to gain a survival advantage. They can activate oncogenes promoting cell proliferation or deactivate tumor suppressor genes removing growth restraints. This adaptability allows cancer cells to become resistant to therapies, evade apoptosis, and metastasize. For instance, mutations in the p53 gene, a crucial tumor suppressor, are common in various cancers and lead to unchecked cell division and survival.
